Choose language / 한국어

EN / 한
릴리, 6.5조원 투자… 유전자 치료제 '날개'
Bull/Bear Index 48.4/100
global ◆ Mixed Impact 30/100 Maeil Business Jan 29, 2026 Read original ↗

릴리, 6.5조원 투자… 유전자 치료제 '날개'

Key takeaway

"릴리, 6.5조원 투자… 유전자 치료제 '날개'" — BullBear's AI rates this story as a mixed, direction-neutral signal, with a market-impact score of 30 out of 100. Reported by Maeil Business on January 29, 2026. The call is verified against the actual 24-hour price move on BullBear's public conviction ledger.

Get the next high-impact catalyst

Telegram alerts when our AI scores a story 80+/100 impact (~1-3 per day, no spam). Verified 30d hit rate 42.3%.

Join Telegram channel

📡 Tomorrow's Watch